n-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide and Brain-Injuries--Traumatic

n-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide has been researched along with Brain-Injuries--Traumatic* in 1 studies

Other Studies

1 other study(ies) available for n-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide and Brain-Injuries--Traumatic

Article	Year
Enhanced Akt/GSK-3β/CREB signaling mediates the anti-inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice. Journal of neurochemistry, 2021, Volume: 156, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Cyclic AMP Response Element-Binding Protein; Glycogen Synthase Kinase 3 beta; Male; Mice; Microglia; Neuroprotective Agents; Niacinamide; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Signal Transduction	2021

Article

Year

Enhanced Akt/GSK-3β/CREB signaling mediates the anti-inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice.

Journal of neurochemistry, 2021, Volume: 156, Issue:2

Topics: Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Cyclic AMP Response Element-Binding Protein; Glycogen Synthase Kinase 3 beta; Male; Mice; Microglia; Neuroprotective Agents; Niacinamide; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Signal Transduction

2021